Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: Possible relationship to the effects on inhibitor of apoptosis protein levels

Chemotherapy

Volumn 51, Issue 5, 2005, Pages 272-279

  Notarbartolo, Monica ^a   Lo Cicero, Salvina ^a   Meli, Maria ^a   Poma, Paola ^a   Labbozzetta, Manuela ^a   Cervello, Melchiorre ^b   D'Alessandro, Natale ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b CNR   (Italy)

Author keywords

A3 adenosine receptor; Apoptosis; IB MECA; Inhibitor of apoptosis proteins; Multidrug resistance

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; DNA FRAGMENT; FAS ANTIBODY; MESSENGER RNA; PHOSPHATIDYLSERINE; PROTEIN INHIBITOR; SURVIVIN; VERAPAMIL; VUF 5574;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE; APOPTOSIS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS;

EID: 23944502274     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087255     Document Type: Article

References (29)

1. Ban T: Pleiotropic, multidrug-resistant phenotype and P-glycoprotein - A review. Chemotherapy 1992;38:191-196.
2. D'Alessandro N, Flugy A, Borsellino N, Travali S: Biology versus pharmacology in drug resistance. Oncol Rep 1997;4:207-210.
3. Reed JC: Dysregulation of apoptosis in cancer. J Clin Oncol 1999;17:2941-2953.
4. Flandina C, Flugy A, Borsellino N, D'Alessandro N: Development and partial characterization of a human T-lymphoblastic leukemic (CCRF-CEM) cell line resistant to etoposide. Analysis of possible circumventing approaches. J Chemother 1996;8:465-471.
5. Li YC, Fung KP, Kwok TT, Lee CY, Suen YK, Kong SK: Mitochondria-targeting drug oligomycin blocked P-glycoprotein activity and triggered apoptosis in doxorubicin-resistant HepG2 cells. Chemotherapy 2004;50:55-62.
6. Tanaka Y, Yoshihara K, Tsuyuki M, Kamiya T: Apoptosis induced by adenosine in human leukemia HL-60 cells. Exp Cell Res 1994;213:242-252.
7. Borsellino N, Crescimanno M, Leonardi V, D'Alessandro N: Effects of 8-chloro-cyclic adenosine monophosphate on the growth and sensitivity to doxorubicin of multidrug-resistant tumor cell lines. Pharmacol Res 1994;30:81-90.
8. Fishman P, Bar Yehuda S, Wagman L: Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth: Possible explanation for the rarity of metastases in muscle. Cancer Res 1998;58:3181-3187.
9. Schrier SM, van Tilburg EW, van der Meulen H, Ijzerman AP, Mulder GJ, Nagelkerke JF: Extracellular adenosine-induced apoptosis in mouse neuroblastoma cells: Studies on involvement of adenosine receptors and adenosine uptake. Biochem Pharmacol 2001;61:417-425.
10. Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz KL, Leung E, Baraldi PG, Borea PA: Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. J Invest Dermatol 2002;119:923-933.
11. 3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp Cell Res 2001;269:230-236.
12. Notarbartolo M, Cervello M, Dusonchet L, Cusimano A, D'Alessandro N: Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possibile relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Lett 2002;180:91-101.
13. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-279.
14. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995;184:39-51.
15. 3 receptor agonists. Biochem Biophys Res Commun 1996;218:904-910.
16. Kim SG, Ravi G, Hoffmann C, Jung YJ, Kim M, Chen A, Jacobson KA: p53-independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA. Biochem Pharmacol 2002;63:871-880.
17. 3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. Mol Pharmacol 2002;61:415-424.
18. 3 receptor. J Med Chem 2000;43:2227-2238.
19. 3 adenosine receptor for cancer therapy: Inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res 2003;23:2077-2083.
20. Lu J, Pierron A, Ravid K: An adenosine analogue, IB-MECA, down-regulates estrogen receptor alpha and suppresses human breast cancer cell proliferation. Cancer Res 2003;63:6413-6423.
21. 3 antagonists. Biochem Biophys Res Commun 1997;232:317-322.
22. Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW: The drug efflux protein, P-glycoprotein, additionally protects drug-resistant cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 1998;95:7024-7029.
23. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-3259.
24. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997;16:6914-6925.
25. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula M, Alnemri ES, Salvesen GS, Reed J: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1997;17:2215-2223.
26. Hu Y, Bally M, Dragowska WH, Mayer L: Inhibition of mitogen-activated protein kinase/ extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis. Mol Cancer Ther 2003;2:641-649.
27. Frankerberger M, Pforte A, Sternsdorf T, Passlick B, Baeuerle PA, Ziegler-Heitbrock HW: Constitutive nuclear NF-kappa B in cells of the monocyte lineage. Biochem J 1994;304:87-94.
28. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS: NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
29. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Richardson PG, Hideshima T, Munshi N, Treon SP, Anderson KC: Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: Therapeutic applications. Blood 2002;99:4079-4086.